As the regular human insulin (RHI) dose increases, there is not only an increase in insulin exposure and metabolic activity but also an increase in the duration of insulin action, which increases the risk of late postprandial hypoglycemia [48]. The gene discussed is INS; the disease is Hypoglycemia.